Immunologic glycosphingolipidomics and NKT cell development in mouse thymus.
Immunologic glycosphingolipidomics and NKT cell development in mouse thymus.
复制标题
DOI:
10.1021/pr801040h
复制
发表时间:
2009-06
影响因子:
4.4
通讯作者:
Zhou D
中科院分区:
文献类型:
--
作者:
Li Y;Thapa P;Hawke D;Kondo Y;Furukawa K;Furukawa K;Hsu FF;Adlercreutz D;Weadge J;Palcic MM;Wang PG;Levery SB;Zhou D
Invariant NKT cells are a hybrid cell type of Natural Killer cells and T cells, whose development is dependent on thymic positive selection mediated by double positive thymocytes through their recognition of natural ligands presented by CD1d, a non-polymorphic, non-MHC, MHC-like antigen presenting molecule. Genetic evidence suggested that β-glucosylceramide derived glycosphingolipids (GSLs) are natural ligands for NKT cells. N-butyldeoxygalactonojirimycin (NB-DGJ), a drug that specifically inhibits the glucosylceramide synthase, inhibits the endogenous ligands for NKT cells. Furthermore, we and others have found a β-linked glycosphingolipid, isoglobotriaosylceramide (iGb3), is a stimulatory NKT ligand. The iGb3 synthase knockout mice have a normal NKT development and function, indicating that other ligands exist and remain to be identified. In this study, we have performed a glycosphingolipidomics study of mouse thymus, and studied mice mutants which are deficient in β-hexosaminidase b or α-galactosidase A, two glycosidases that are up- and down-stream agents of iGb3 turnover, respectively. Our mass spectrometry methods generated a first database for glycosphingolipids expressed by mouse thymus, which are specifically regulated by rate-limiting glycosidases. Among the identified thymic glycosphingolipids, only iGb3 is a stimulatory ligand for NKT cells, suggesting that large scale fractionation, enrichment and characterization of minor species of glycosphingolipids, be necessary for identifying additional ligands for NKT cells. Our results also provide early insights into cellular lipidomics studies, with a specific focus on the important immunological functions of glycosphingolipids.
登录
查看更多内容
DOI:
10.1084/jem.20060921
发表时间:
2006-10-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Gadola SD;Silk JD;Jeans A;Illarionov PA;Salio M;Besra GS;Dwek R;Butters TD;Platt FM;Cerundolo V
通讯作者:
Cerundolo V
DOI:
10.1073/pnas.94.6.2540
发表时间:
1997-03-18
影响因子:
11.1
作者:
Ohshima, T;Murray, GJ;Kulkarni, AB
通讯作者:
Kulkarni, AB
DOI:
10.1016/j.jasms.2003.12.007
发表时间:
2004-04-01
影响因子:
3.2
作者:
Hsu, FF;Turk, J
通讯作者:
Turk, J
影响因子:
30.5
作者:
Kinjo, Yuki;Tupin, Emmanuel;Kronenberg, Mitchell
通讯作者:
Kronenberg, Mitchell
影响因子:
64.8
作者:
Mattner, J;DeBord, KL;Bendelac, A
通讯作者:
Bendelac, A